​Bech P, Loldrup D, Garre K, Rasmussen K, Ærenlund Jensen H. Livskvalitetsmå¬ling som effektstørrelse ved behandling af essentiel arteriel hypertension. Ugeskr Læger 1990; 152/6, 383-386.​​

Kragh-Sørensen P, Holm P, Fynboe C, Andersen B, Bech P, Pichard J. Bromazepam in generalized anxiety. Psychopharmacology 1990; 100: 383-386.​​

Bech P, Hjortsø S. Problems in measuring quality of life in schizophrenia. Nord Psykiatr Tidsskr 1990; 44: 77-79.​

Wistedt B, Rasmussen A, Petersen L, Malm U., Träskman-Bendz, L., Berggren, M., Wakelin, J., Bech P. The development of an observer scale for measuring social dysfunction and aggression. Pharmacopsychiatry 1990; 23: 249-252.

Bech P. Measurement of psychological distress and well-being. Psychother Psychosom 1990; 54: 77-89.

Danish University Antidepressant Group (DUAG). Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipra¬mine in a controlled multicenter study. J Affect Dis 1990; 18: 289-299.

Møller SE, Bech P, Bjerrum, H., Bøjholm S, Butler B, Folker, H., Gram LF, Larsen JK, Lauritzen L, Loldrup D, Munk-Andersen,E, Ødum K, Rafaelsen OJ. Plasma ratio tryptophan¬/neutral amino acids in relation to clinical response to paroxetine and clomipramine in patients with major depression. J Affect Dis 1990; 18: 59-66.

World Health Organization Collaborative Study. Validity of Imipramine Platelet Binding Sites as a Biological Marker of Endogenous Depression. Pharmacopsychiatry 1990; 23: 113-117.

Bech P. A meta-analysis of the antidepressant properties of serotonin reuptake inhibitors. Internat Rev Psychiatry 1990; 2: 207-211.

Bech P. Rating scales for anxiety and depression: content and construct validity. J Psychiat Res 1990; 24 (suppl. 1): 73-74.

Bech P. Psychometric Developments of the Hamilton Scales: The spectrum of depression, dysthymia and anxiety. Acta et Commentationes Universitatis Tartuensis 1990; 895: 15-26.

Bech P. Diagnostische en classificatiesystemen met een bijzondere nadruk op het Mini-compendium. Acta Neuropsychiatr 1990; 2,2: 38-42.

Maier W, Albus M, Buller R, Nutzinger D, Shera D, Bech P. Self- and observer assessment in anxiolytic drug trials: A comparison of their validity. Eur. Arch Psychiatry. Clin Neurosci 1990; 240: 103-108.

Albus M, Maier W, Shera D, Bech P. Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales. Eur Arch Psychiatry Clin Neurosci 1990; 240: 96-102.

Bech P. The proper use of rating scales in depression. Focus on Depression, 1990; vol. 1: 12: 76-85.

Ærenlund Jensen H, Rasmussen K, Garre K, Waldorf S, Loldrup Poulsen D, Bech P. Behandlingen af hypertension i almen praksis, konsekvenser af behandlings¬skift. Ugeskr Læger 1991; 153: 1204-1207.

Argyle N, Deltito J, Allerup P, Maier W, Albus M, Nutzinger D, Rasmussen S, Ayuso JL, Bech P. The Panic-Associated Symptom Scale: measuring the severity of panic disorder. Acta Psychiatr Scand 1991; 83: 20-26.

Bech P. Treatment-related quality of life. Quality of Life Newsletter 1991; 3: 3.
Lund, H.G., Bech P, Eplov L, Jennum, P., Wildschiødtz, G. An epidemiological study of REM latency and psychiatric disorders. J Affect Dis 1991; 23: 107-112.

Frimodt-Møller J, Loldrup Poulsen D, Kornerup HJ, Bech P. Quality of life, side effects and efficacy of lisinopril compared with metoprolol in patients with mild to moderate essential hypertension. J Hum Hypertension 1991; 5: 215-221.

Loldrup D, Langemark M, Hansen, H.J., Kastrup M, Jeppesen K, Bonnevie O, Elsborg E, Olesen J, Bech P. The validity of the Melancholia Scale (MES) in predicting outcome of antidepressants in chronic idiopathic pain disorders. Eur Psychiatry 1991; 6: 119-125.

Bech P. Clinical target syndromes in psychiatry: latent structure analysis versus factor analysis. Eur Psychiatry 1991; 6: 301-306.

Angst J, Bech P, Engel R, Hippius H, Janzen GJ, Lecrubier Y, Lingjaerde O, Möller JJ, Montgomery S, Paes de Sousa M, Rossi A, Saletu B, Sedvall G, Stefanis C, Stoll K-D, Woggon B. Report on the Third Consensus Conference on the Methodology of Clinical Trials with Antipsychotic Drugs. Pharmacopsychiatry 1991; 24: 149-152.

European Rating Aggression Group (ERAG). Social dysfunction and aggression scale (SDAS-21) in generalized aggression and in aggressive attacks: A validity and reliability study. Int J Meth Psychiatr Res 1992; 2: 15-29.

Bech P, Allerup P, Maier W, Albus M, Lavori, P., Ayuso, J.L. The Hamilton Scales and the Hopkins Symptom Checklist (SCL-90). A Cross-National Validity Study in Patients with Panic Disorders. Br J Psychiatry 1992; 160: 206-211.

Bech P, Cialdella, P. Citalopram in Depression. Meta-analysis of Intended and Uninten¬ded Effects. Clin Psychopharmacol 1992; 6 (suppl. 5): 43-52.

Øhrberg S, Christiansen PE, Severin, B, Calberg H, Nilakantan B, Borup A, Søgaard J, Larsen SB, Loldrup D, Bahr B, Siebuhr N, Gregersen B, Jacobsen F, Liljeström M, Manniche PM, Bech P. Paroxetine and imipramine in the treatment of depressive patients in psychiatric practice. Acta Psychiatr Scand 1992; 86: 437-444.

Bech P, Tørning J. Alkoholisme. Psykopatologi og livskvalitet. Månedsskr Prakt Lægegerning 1992; 9: 786-797.

Lauritzen L, Clemmesen L, Klysner R, Loldrup D, Lunde, M., Schaumburg E, Waarst S, Bech P. Combined treatment with imipramine and mianserin. A controlled pilot study. Pharmacopsychiatry 1992; 4: 182-186.

Bech P. Measuring quality of life: The medical perspective. Nord J Psychiatry 1992; 46: 85-89.

Bjerrum H, Allerup P, Thunedborg K, Jakobsen K, Bech P. Treatment of generalized anxiety disorder: Comparison of a new beta-blocking drug (CGP361A), low-dose neuroleptic (flupenthixol), and placebo. Pharmacopsychiatry 1992; 5: 229-232.

Klerman GL, Bech P, Benkert O. et al. Drug treatment of panic disorder. Reply to comment by marks and associates. Br J Psychiatry 1992; 161: 465-471.

Bech P. Quality of life measurement in the medical setting. Int J Methods Psychiat Res 1992; 2: 139-144.

Bech P. Den kliniske betydning af negative og positive symptomer ved skizofreni. Nord Psykiatr Tidsskr 1992; 46 (suppl. 26): 23-27. 

Bech P, Allerup P, Maier W, Albus M, Lavori P, Ayuso JL. Insight and illusion. Br J Psychiatry 1992; 161: 716-717.

Mellerup ET, Bech P, Lauritzen L, Lunde M, Plenge P. Rapid Communication. Platelet paroxetine binding in alcoholics. Alcohol & Alcoholism 1992; 27: 603-606.

Rasmussen S, Bech P. Citalopram in the treatment of depression in specialist practice morning vs evening administration. Poster abstract. In: Robert P et al (eds) Proceedings of the 18th CINP Congress. Clinical Neuropharmacology 1992; 15 (suppl 1, pt B): 529B

Bech P. Quality of life measurements in chronic disorders. Psychother Psychosom 1993; 59: 1-10.

Angst J, Ansseau M, Bech P, Engel RR, Hippius H, Lader, M., Lecrubier Y, Lingjaerde O, Paes de Sousa M, Rossi A, Rüther E, Saletu B, Stefanis CN, Stoll KD, Westenberg GM, Woggon B. Report on the fourth consensus conference on the methodology of clinical trials with anxiolytic drugs. Pharmacopsychiatry 1993; 26: 1-5.

Bech P. Health-related quality of life. An editorial. Annals Med 1993; 25: 103-104. 
Thunedborg K, Allerup P, Bech P, Joyce CRB. Development of the Repertory Grid for measurement of individual quality of life in clinical trials. Int J Meth Psychiatr Res 1993; 3: 48-58.
Bech P. Acute therapy of depression. J Clin Psychiatry 1993; 54 (suppl 8): 18-27. 
Bech P. The Hamilton disorders. An editorial. Psychother Psychosom 1993; 60: 113-115.

Frimodt-Møller J, Loldrup Poulsen D, Kornerup HJ, Bech P. Livskvalitet, bivirkninger og effekt på blodtrykket af lisinopril og metoprolol ved mild til moderat essentiel hypertension. Ugeskr Læger 1993; 13: 967-970.

Rosenberg R, Rosenberg NK, Bech P, Rasmussen SB., Mellergård M, Lorentzen KD. Panikangst. Patienters somatiske kontaktmønster. Ugeskr Læger 1993; 16: 1195-1198.

Bech P, Malt UF, Dencker SJ, Ahlfors UG, Elgen K, Lewander T, Lundell A, Simpson GM, Lingjærde O. Scales for assessment of diagnosis and severity of mental disorders. Acta Psychiatr Scand 1993; 87; (suppl. 372)

Gerlach J, Korsgaard S, Clemmesen P, Lund Lauersen A-M, Magelund G, Noring U, Povlsen UJ, Bech P, Casey DE. The St. Hans Rating Scale for extrapyramidel syndromes: reliability and validity. Acta Psychiatr Scand 1993; 87: 244-252.

Bech P. Measurement of Clinical Anxiety by Rating Scales: A review. Torture 1993; (suppl. 1): 13-18.

Danish University Antidepressant Group. Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Dis 1993; 28: 105-116.

Bech P, Malt UF, Dencker SJ, Ahlfors UG, Elgen K, Lewander T, Lundell, A, Simpson GM, Lingjærde O. Scales for Assessment of Diagnosis and Severity of Mental Disorders. Acta Psychiatrica Scand. 1993; 87 (suppl. 372): 1-87.

Buchholtz-Hansen PE, Wang AG, Kragh-Sørensen P. and the Danish University Antidepressant Group (DUAG). Mortality in major affective disorder: relationship to subtype of depression. Acta Psychiatr Scand 1993; 87: 329-335.

Bech P. Misurazione della sofferenza e del benessere psicologici. Boll Psicolog Appl 1993; 205: 15-27.

Kelstrup A, Lund K, Lauritsen B, Bech P. Satisfaction with care reported by psychiatric inpatients. Relationship to diagnosis and medical treatment. Acta Psychiatr Scand. 1993; 87: 374-379.

Vestergaard P, Gram LF, Kragh-Sørensen P, Bech P, Reisby N, Bolwig TG. Therapeutic potentials of recently introduced antidepressants. Danish University Antidepressant Group. Psychopharmacol Ser. 1993;10:190-198 [Springer]

Bech P. The borderline syndromes of depression, mania and schizophrenia: the coaxial or temperamental approach. Acta Psychiatr Scand Suppl 1994; 379:45-49

Lauritzen L, Bjerg Bendsen B, Vilmer T, Bjerg Bendsen, E, Lunde M, Bech P. Post-stroke depression: combined treatment with imipramine or desipramine and mianserin. A controlled clinical study. Psychopharmacology 1994; 114: 119-122.

Bech P. Issues of Concern in the Standardization and Harmonization of Psychotropic Drug Trials in Europe. Methodological Issues in Psychotropic Drug Trials (ECST). An editorial. Europ Psychiatry 1994; 9: 113-114.

ECST Strasbourg Forum - 18-19 June 1992. Europ Psychiatry 1994; 9: 155-160.

Middelboe T, Ovesen L, Mortensen EL, Bech P. Depressive symptoms in cancer patients undergoing chemotherapy. A psychometric analysis. Psychother Psychosom 1994; 61: 171-177. 

Bech P. Measurement by observations of aggressive behaviour and activities in clinical situations. Crim Behav Ment Health 1994; 4: 290-302.

Bech P. The borderline syndromes of depression, mania and schizophrenia: the coaxial or temperamental approach. Acta Psychiatr Scand 1994: 89 (suppl 379): 45-49 

Angst J, Bech P, Bruinvels, J. Report on the fifth concensus conference: Methodology of long-term clinical trials in psychiatry. Pharmacopsychiatry 1994; 27: 101-107.

Allerup P, Bech P, Loldrup D, Alvarez P, Banegil T, Styles I, Tenenbaum G. Psychiatric, business, and psychological applications of fundamental measurement models. Int J Educational Res 1994; 4: 611-622.

Jess P, Bech P. and the Hvidovre Ulcer Project Group. The validity of Eysenck’s Neuroticism Dimension within the Minnesota Multiphasic Personality Inventory in Patients with Duodenal Ulcer. Psychother Psychosom 1994; 62: 168-175.

Bech P. Quality-of-Life Measurements for Patients Taking Which Drugs? The clinical PCASEE Perspective. PharmacoEconomics 1995; 7: 141-151.

Bech P. Depression - screening og behandling. Månedsskr Prakt Lægegern 1995; 4: 529-547.

Bent-Hansen J, Lauritzen L, Clemmesen L, Lunde M, Kørner A. A definite and a semidefinite questionnaire version of the Hamilton/melancholia (HDS/MES) scale. J Aff Dis 1995; 33: 143-150.

Kielholz P, Adams C, Bech P, Bocksberger JP, Crombecque A, de Girolamo G, Fayolle K, Holsboer E, Katschnig H, Korten A, Küng A, Meyer JW, Pöldinger W, Prilipko L, Reubi I, Sartorius N. Depression and cognitive impairment in the elderly: a multicentre study. Eur Psychiatry 1995; 10: 61-74.

Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN. Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995; 63: 1-8.

Thunedborg K, Black C, Bech P. Beyond the Hamilton Depression Scores in long-term treatment of manic-melancholic patients: prediction of recurrence of depression by quality of life measurements. Psychother Psychosom 1995; 64: 131-140.

Bech P. Social aspects of treatment of depression. Int Clin Psychopharmacol 1995; 10 (suppl 1): 11-14.

Bech P. Nyt redskab i depressionsdiagnostik (PRIME-MD). Månedsskr Prakt Lægegern 1996; 74: 343-351.

Bech P, Angst J. Quality of life in anxiety and social phobia. Clin Psychopharmacol 1996; 11 (suppl 3): 16-20.

Lauritzen L, Odgaard K, Clemmesen L, Lunde M, Öhrström J, Black C, Bech P. Relapse prevention of paroxetine in ECT treated patients with major depression. A comparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 1996; 94: 241-251. 

Fuglum E, Rosenberg C, Damsbo N, Stage K, Lauritzen L, Bech P and DUAG. Screening and treating depressed patients. A comparison of two controlled citalopram trials across treatment settings: Hospitalized patients vs. patients treated by their family doctors. Acta Psychiatr Scand 1996; 94: 18-25.

Bech P, Gudex C, Staehr Johansen K. The WHO (Ten) Well-Being Index: Validation in Diabetes. Psychother Psychosom 1996; 65: 183-190.

Bech P. Quality of life measurements in major depression. Eur Psychiatry 1996; 11: 123-126.

Kørner A, Lauritzen L, Bech P. A psychometric evaluation of dementia rating scales. Eur Psychiatry 1996; 11: 185-191

Bech P. Understanding depression. WPA Teaching Bulletin 1996; 3: 1-3

Bech P, Stage KB, Nair NPV, Larsen JK, Kragh-Sørensen P, Gjerris A and DUAG. The major depression rating Scale (MDS). Inter-rater reliability and validity across different settings in randomized moclobemide trials. J Affect Disord 1997; 42: 39-48.

Bech P. Quality of life instruments in depression. Eur Psychiatry 1997; 12: 194-198

Bech P. Sundhedsrelateret livskvalitet, lykkepiller og depression. Lægemagasinet 1997; 3: 34-36

Bech P. Diagnostik af depressioner. Månedsskr Prakt Lægegern Juni 1997, 773-781

Bech P. The Measurement of health-related quality of life. (Paper presented at 29th Nordic Congress of Gastroenterology). Scand J Gastroenterol 1997; 32 Suppl 224: 21

Bjerg Bendsen B., Bjerg Bendsen E, Lauritzen L, Vilmer T, Bech P. Post-stroke patients in rehabilitation. The relationship between biological impairment (CT scanning), physical disabilitity and clinical depression. Eur Psychiatry 1997;12:399-404

Lauritzen L, Odgaard K, Clemmesen L, Lunde M, Öhrström J, Black C, Bech P. The impact of treatment resistance on depressive relapse following electroconvulsive therapy. Acta Psychiatr Scand 1997; 96:405-406

Bech P. Hvordan diagnosticeres depression hos alvorligt syge og døende patienter? Differentialdiagnostiske overvejelser. OMSORG - Nord Tidsskr Palliat Med 1997;4: 42-46

Becker N, Bondegaard Thomsen A, Olsen AK, Sjøgren P, Bech P, Eriksen J. Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain 1997, 73: 393-400

Bech P, Grosby H, Hoffmann G, Rafaelsen OJ, Theilgaard A. Bilkørsel i laboratoriet. Har fenemal og fenytoin nogen virkning? Tidsskr Epilepsi 1997; 11:4-6

Dam J, Ryde L, Svejsø J, Lauge N, Lauritsen B, Bech P. Morning fluoxetine plus evening mianserin versus vorning fluoxetine plus evening placebo in the acute treatment of Major Depression. Pharmacopsychiatry 1998, 31: 48-54

Lauge N, Behnke K, Søgaard J, Bahr B, Bech P. Responsiveness of observer rating scales by analysis of number of days until improvement in patients with major depression.Eur Psychiatry 1998; 13: 143-145

Jess P, Jess T, Beck H, Bech P. Neurotic248ism in Relation to Recovery and Persisting Pain after Laparoscopic Cholecystectomy249 .Scand J Gastroenterol 1998; 33: 550-553

Wermuth L, Sørensen PS, Timm S, Christensen B, Utzon NP, Boas J, Dupont E, Hansen E, Magnussen I, Mikkelsen B, Worm-Petersen J, Lauritzen L, Bayer L, Bech P. Depression in idiopathic Parkinson’s disease treated with citalopram. A placebo-controlled study. Nord J Psychiatry 1998; 52: 163-169

Bech P, Munk-Jensen N, Obel EB, Ulrich LG, Eiken P, Nielsen SP. Combined versus Sequential Hormonal Replacement Therapy: A Double-Blind, Placebo-Controlled Study on Quality of Life-Related Outcome Measures. Psychother Psychosom 1998; 67:259-265

Bech P, Wermuth L . Applicability and validity of the Major Depression Inventory in patients with Parkinson's Disease. Nord Psykiatr Tidsskr 1998; 52: 305-309

Bech P, Peuskens JCJR, Marder SR, Chouinard G, Høyberg OJ, Huttunen MO, Blin O, Claus A. Meta-analytic study of the benefits and risk of treating chronic schizophrenia with risperidone or conventional neuroleptics. Eur Psychiatry 1998; 13: 310-4

Becker N, Thomsen AB, Olsen AK, Sjøgren P, Bech P, Eriksen J. Smerteepidemiologi og helbredsrelateret livskvalitet hos patienter med kroniske ikkemaligne smerter. Ugeskr Læger 1998; 160: 6816-6819

Bullinger M, Alonso J, Apolone G, Leplège A, Sullivan M, Wood-Dauphinee S, Gandek B, Wagner A, Aaronson N, Bech P, Fukuhara S, Kaasa S, Ware JE. Translating health status questionnaires and evaluating their quality: The IQOLA Project approach. J Clin Epidemiol 1998; 51: 913-923

Bjørner JB, Thunedborg K, Kristensen T, Modvig J, Bech P. The Danish SF-36 health survey: Translation and preliminary validity studies. J Clin Epidemiol 1998; 51: 991-999

Ware J, Kosinski M, Gandek B, Aaronson N Apolone G, Bech P, Brazier J, Bullinger M, Kaasa S, Leplège A, Prieto L, Sullivan M. The factor structure of the SF-36 health survey in 10 countries: Results from the IQOLA project. J Clin Epidemiol 1998; 51: 1159-1165

Bjørner JB, Kreiner S, Ware JE, Damsgaard MT, Bech P. Differential item functioning in the Danish translation of the SF-36. J Clin Epidemiol 1998; 51: 1189-1202.

Raczek AE, Ware JE, Bjørner JB, Gandek B, Haley SM, Aaronson NK, Apolone G, Bech P, Brazier JE, Bullinger M, Sullivan M. Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: Results from the IQOLA project. J Clin Epidemiol 1998; 51: 1203-1214.

Heun R, Burkart M, Maier W, Bech P. Internal and external validity of the WHO Well-Being Scale in the elderly general population. Acta Psychiatr Scand 1999; 99: 171-178

Bech P, Raabæk Olsen L, Jarløv N, Hammer M, Schütze T, Breum L. A case of sequential anti-stress medication in a patient with major depression resistant to amine-reuptake inhibitors. Acta Psychiatr Scand 1999; 100: 76-78

Christensen S, Bundgaard S, Bech P. Prævalens af middelsvær depression i almen praksis ved brug af PRIME-MD. Månedsskr Prakt Lægegern 1999; 77: 937-950

Dreisig H, Beckmann J, Wermuth L, Skovlund S, Bech P. Psychologic effects of structured cognitive psychotherapy in young patients with Parkinson disease: A pilot study. Nord J Psychiatry 1999; 53: 217-221 

Groenvold M, Fayer PM, Sprangers MAG, Bjorner JB, Klee MC, Aaronson NK, Bech P, Mouridsen HT. Anxiety in breast cancer patients at low risk of recurrence compared with the general population: a valid comparison? J Clin Epidemiol 1999; 52: 523-530

Bech P. Health-related quality of life measurements in the assessment of pain clinic results. Acta Anaesthesiol Scand 1999; 43: 893-896

Peuskens J, Bech P, Möller H-J, Bale R, Fleurot O, Rein W. Amisulpride vs. risperidone in the treatment of acute exacerbations of schizophrenia. Psychiatry Res 1999; 88: 107-117

Danish University Antidepressant Group (DUAG). Clomipramine dose-effect study in patients with depression: Clinical end points and pharmacokinetics. Clin Pharmacol Therapeut 1999; 66: 152-165

Rasmussen NA, Norholm V, Bech P. The internal and external validity of ”The Psychological General Well-Being Schedule” (PGWB). Quality of Life Newsletter 1999; 22: 7

Bech P, Cialdella P, Haugh M, Birkett MA, Hours A, Boissel JP, Tollefson GD. A meta-analysis of randomised controlled trials of fluoxetine versus placebo and tricyclic antidepressants in the short-term treatment of major depression. Br J Psychiatry 2000; 176: 421-428

Bech P. A case report showing that subclinical hypothyroidism rather than hyperthyroidism stabilizes rapidly cycling bipolar illness. Psychother Psychosom 2000; 69: 110-111

Becker N, Sjøgren P, Bech P, Olsen AK, Eriksen J. Treatment outcome of chronic non-malignant pain patients managed in a Danish multidisciplinary pain centre compared to general practice: a randomised controlled trial. Pain 2000; 84: 203-211

Årsland D, Larsen JP, Lim NG, Wermuth L, Bech P. 2-Adrenoreceptor antagonism and serotonin reuptake inhibition in patients with Parkinson disease and depression. Nord J Psychiatry 2000; 54;: 411-415.

Watt T, Groenvold M, Bjorner JB, Noerholm V, Rasmussen N-A, Bech P. Fatigue in the Danish general population. Influence of sociodemographic factors and disease. J Epidemiol Comm Health 2000; 11: 827-833

Bech P. The significance of delusions in depressive disorders. Curr Opin Psychiatry 2001; 14: 47-49

Bech P & Olsen LR. Om opsporing af depression. Ugeskr Læger 2001; 163: 1980-1982

Christensen O, Bundgaard S, Bech P. Prevalence of clinical (major) depression in general practice using the DSM-IV version of PRIME-MD. Int J Psychiatry Clin Pract 2001; 5: 49-54

Bech P, Baastrup PC, de Bleeker E, Ropert P. Dimensionality, responsiveness and standarsization of the Bech-Rafaelsen Mania Scale in the ultra-short therapy with antipsychotics in patients with severe manic episodes. Acta Psychiatr Scand 2001; 104: 25-30

Fountoulakis KN, Iacovides A, Kleanthous S, Samolis S, Kaprinis SG, Sitzoglou K, Kaprinis GS, Bech P. Reliability, validity and psychometric properties of the Greek translation of the Center for Epidemiological Studies - Depression (CES-D) Scale. BioMed Central (BMC) 2001;1:3 (www.biomedcentral.com/1471-244X/1/3)

Schuetze T, Nørholm V, Olsen LR, Hougaard H, Ekstrøm M, Wagn P, Bech P. Reliability and validity of the Calgary Depression Scale for schizophrenia. Nord J Psychiatry 2001; 55: 119-122

Bech P, Rasmussen N-A, Olsen LR, Noerholm V, Abildgaard W. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 2001; 66: 159-164

Fountoulakis KN, Karamouzis M, Iacovides A, Nimatoudis J, Diakogiannis J, Kaprinis G, Demitriadou A, Bech P. Morning and evening plasma melatonin and Dexamethasone Suppression Test in patients with nonseasonal disorder from Northern Greece (latitude 40-41.5o). Neuropsychobiology 2001; 44: 113-117

Bech P. Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression. Int J Neuropsychopharmacol 2001; 4: 337-345

Nørholm V, Bech P. The WHO Quality of Life (WHOQOL) Questionnaire: Danish validation study. Nord J Psychiatry 2001; 55: 229-235

Holm J, Holm L, Bech P. Monitoring improvement using a patient-rated depression scale during treatment with anti-depressants in general practice. Scand J Prim Care 2001; 19: 263-266

Nørholm V, Bech P, Svensson L. Individual quality of life in schizophrenic patients - description and applicability of GRIDQoL in a computer based version. Int J Methods Psychiatr Res 2001; 10: 134-139

Bech P. The Bech-Rafaelsen Mania Scale in clinical trials of therapies for bipolar disorder: 20-year review of its use as an outcome measure. CNS Drugs 2002; 16: 47-63

Stage KB, Bech P, Kragh-Sørensen P and the Danish University Antidepressant Group. Age-related adverse drug reactions to clomipramine. Acta Psychiatr Scand 2002; 105: 55-59

Bech P. Socialfobi. Månedsskr Prakt Lægegern 2002.; 80: 491-96
Zierau F, Bille A, Rutz W, Bech P. The Gotland Male Depression Scale: A validity study in patients with alcohol use disorder. Nord J Psychiatry 2002; 56: 265-271

Bech P, Tanghøj P, Andersen HF, Overø K. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression. Psychopharmacol 2002; 163: 20-25

Montgomery SA, Bech P, Blier P, Möller H-J, Nierenberg AA, Pinder RM, Quitkin FM, Reimitz PE, Rosenbaum JF, Rush J, Stassen HH, Thase ME. Selecting methodologies for the evaluation of differences in time to response between antidepressants. J Clin Psychiatry 2002; 63:8

Bech P. The Bech-Rafaelsen Melancholia Scale (MES) in clinical trials of therapies in depressive disorders: a 20-year review of its use as outcome measure. Acta Psychiatr Scand 2002; 106: 252-264

Jess P, Christiansen J, Bech P. Quality of life after anterior resection versus abdominoperineal extirpation for rectal cancer. Scand J Gastroenterol 2002; 10: 1201-1204

Bech P, Lunde M, Undén M. Social Adaptation Self-evaluation Scale (SASS): Psychometric analysis as outcome measure in the treatment of patients with major depression in the remission phase. Int J Psychiatry Clin Pract 2002; 6: 141-146

Fountoulakis KN, Iacovides A, Kleanthous S, Samolis S, Gougoulia K, Kaprinis SG, Bech P. Reliability, validity and psychometric properties of the Greek translation of the Major Depression Inventory. BMC Psychiatry 2003, 3:2, http://www.biomedcentral.com/bmcpsychiatr/

Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P. The internal and external validity of the Major Depression Inventory in measuring severity of depressive states. Psychol Med 2003; 33, 351-356

Bech P, Moses R, Gomis R. The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy-naïve Type 2 diabetes: a placebo-controlled, multicentre study. Qual Life Res 2003; 12: 413-425

Bech P, Olsen RL, Kjoller M, Rasmussen NK. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int J Meth Psychiatr Res 2003; 12: 85-91

Bech P. Commentary [to: Kocsis J et al. 18-month maintenance treatment with sertraline may have sustained psychosocial benefits in chronic depression, Arch Gen Psychiatry 2002; 59: 723-728]. Evidence-based Mental Health 2003; 6: 49

Bech P, Lucas M, Amir M, Bushnell D, Martin M, Buesching D, and the LIDO Group. Association between clinically depressed subgroups, type of treatment, and patient retention in the LIDO study. Psychol Med 2003; 33: 1051-1059

Bech P, Bille J, Schutze T, Sondergaard S, Wiese M, Waarst S. Health of the Nations Outcomes Scale (HoNOS): Implementability, subscale structure and responsiveness in the daily psychiatric hospital routine over the first 18 months. Nord J Psychiatry 2003; 57:285-290

Rasmussen A, Lunde M, Poulsen DL, Sørensen K, Qvitzau S, Bech P. A double-blind, placebo-controlled study in the prevention of depression in stroke patients. Psychosomatics 2003; 44: 216-221

Fountoulakis KN, Iacovides A, Kleanthousmailto:kfount@med.auth.gr S, Samolis S, Gougoulias K, Kaprinis GN, Bech P. The Greek translation of the Symptoms Rating Scale for Depression and Anxiety: preliminary results of the validation study. BMC Psychiatry 2003, 3:21. http://www.biomedcentral.com/1471-244X/3/21

Bent-Hansen J, Lunde M, Klysner R, Andersen M, Tanghøj P, Solstad K, Bech P. The validity of the depression rating scales in discriminating between citalopram and placebo in depression recurrence in the maintenance therapy of elderly unipolar patients with major depression. Pharmacopsychiatry 2003; 36: 313-316

Olsen LR, Mortensen EL, Bech P. Prevalence of major depression and stress indicators in the Danish general population. Acta Psychiatr Scand. 2004;109:96-103

Martiny K. Adjunctive bright light in non-seasonal major depression. Acta Psychiatr Scand Suppl. 2004;(425):7-28

Martiny K, Lunde M, Simonsen C, Clemmensen L, Poulsen DL, Solstad K, Bech P. Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy. A placebo-controlled study. Acta Psychiatr Scand 2004;109: 230-234

Noerholm V, Groenvold M, Watt T, Bjorner JB, Rasmussen N-A, Bech P. Quality of life in the Danish general population - normative data and validity of WHOQOL-BREF using Rasch and item response theory models . Qual Lif Res 2004; 13: 531-540 

Fountoulakis KN, Iacovides A, Grammaticos P, Kaprinis GS, Bech P. Thyroid Function in Clinical Subtypes of Major Depression: an exploratory study. BMC Psychiatry 2004, 4:6. http://www.biomedcentral.com/1471-244X/4/6

Bech P. Measuring the dimensions of psychological general well-being by the WHO-5. QoL Newsletter 2004; 32: 15-16.

Martiny K, Simonsen C, Lunde M, Clemmensen L, Bech P. Decreasing TSH levels in patients with Seasonal Affective Disorder (SAD) responding to 1 week of bright light therapy. J Affect Disord 2004; 79: 253-257

Fountoulakis KN, Iacovides A, Fotiou F, Nimatoudis J, Bscialla F, Ioannidou C, Kaprinis G, Bech P. Neurobiological and psychological correlates of suicidal attempts and thoughts of death in patients with major depression. Neuropsychobiology 2004; 49: 42-52

Bech P, Tanghøj P, Cialdella P, Friis Andersen H, Pedersen AG. Escitalopram dose–response revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression. Int J Neuropsychopharmacol 2004;7:283-290.

Hvass A-M, Juul S, Bech P, Nexø E. Vitamin B6 level is associated with symptoms of depression. Psychother Psychosom 2004; 73: 340-343

Olsen LR, Mortensen EL, Bech P. The SCL-90 and SCL-90R versions validated by item response theory models in a Danish community sample. Acta Psychiatr Scand 2004: 110: 225-229

Sørensen S, Friis-Hasché, Haghfelt, Bech P. Postmyocardial infarcation mortality in relation to depression: A systematical critical review. Psychother Psychosom 2005; 74: 69-80

Licht RW, Qvitzau S, Allerup P, Bech P. Validation of the Bech-Rafaelsen Melancholia Scale and the Hamilton Depression Scale in patients with major depression: is the total score a valid measure of illness severity? Acta Psychiatr Scand 2005; 111: 144-149

Sørensen C, Friis-Hasché E, Haghfelt T, Bech P. Postmyocardial infarction mortality in relation to depression: a systematic critical review. Psychother Psychosom 2005; 74: 69-80

Sørensen C, Brandes A, Hendricks O, Thrane J, Friis-Hasché E, Haghfelt T, Bech P. Psychosocial predictors of depression in patients with acute coronary syndrome. Acta Psychiatr Scand 2005; 111: 116-124

Bech P. Social functioning. Should it become an endpoint in trials of ad Should it become an endpoint in trials of antidepressants? Review article. CNS Drugs 2005; 19: 313-324

Rasmussen N-A, Schrøder P, Olsen LR, Brødsgaard M, Undén M, Bech P. Modafinil augmentation in depressed patients with partial response to antidepressants: A pilot study on self-reported symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92). Nord J Psychiatry 2005; 59: 173-178

Andersen TH, Bech P, Larsen N-E. Switching patients from olanzapine or risperidone to a combination treatment using perphenazine plus buspirone: Evaluation of antipsychotic efficacy and side-effects, including extrapyramidal effects and weight loss. Nord J Psychiatry 2005; 59: 205-208

Rasmussen N-A, Schrøder P, Olsen LR, Brødsgaard M, Undén M, Bech P. Modafinil augmentation in depressed patients with partial response to antidepressants: A pilot study on self-reportes symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92). Nord J Psychiatry 2005; 59: 173-178

Martiny K, Lunde M, Undén M, Dam H, Bech P. Adjunctive bright light in non-seasonal major depression: Results from clinician-rated depression scales. Acta Psychiatr Scand 2005; 112: 117-125

Bech P, Lunde M, Undén M. An inventory for the measurement of generalised anxiety distress symptoms, the GAD-10 Inventory. Acta Psychiatr Belg 2005; 105:111-118

Bech P, Andersen MB, Bech-Andersen G, Tønnesen S, Agnarsdottir E, Borg V. Work-related stress, depression and quality of life in Danish managers. Eur Psychiatry 2005 (suppl 3): S318-S325

Bech P, Jha SK. Rating scales in psychiatry - an introduction. Lundbeck: CNS Forum (Practice: rating scales: psychiatry). www.cnsforum.com
Bech P. Bipolar lidelse og behandling. Læge-Helse Overblik 2004; 9 (12): 17-18

Bech P. Hvordan er sammenhængen mellem angst/socialfobi – og hvordan behandles det – med antidepressiva/psykoterapi? InfoMed 2005;16:1
a) Licht RW, Bech P. Letter to the Editor. Am J Psychiatry 2005; 162: 2394-2395
​b) Bech P and the DRSS team. Letter to the Editor. Am J Psychiatry 2005; 162: 2396

Martiny K, Lunde M, Undén M, Dam H, Bech P. Adjunctive bright light in non-seasonal major depression: Results from patient-reported symptom and well-being scales. Acta Psychiatr Scand 2005;111:453-459.

Power M, Quinn K, Schmidt S and the WHOQOL Group*. Development of the WHOQOL-Old module. Qual Life Res 2005; 14: 2197-2214
*incl. Martiny K

Martiny K. Lysbehandling af søvn og adfærds forstyrrelser samt depression ved demens. Statusartikel på baggrund af Cochrane review: Light therapy for managing sleep, behaviour and mood disturbances in dementia. Ugeskrift for Læger 2006;168:1317-1320.​
​